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SHORT COMMUNICATION 
Phospholipid labelling by [32P]-orthophosphate and [ 3H]-myo-inositol in the stimulated 
goldfish brain in vivo' 
(Received 29 December 1971. Accepted 8 February 1972) 
THE RAPID turnover of phosphatidate (PhA) and phosphatidyl inositol (PhI) in neural tissue has been 
related to synaptic function by a number of observations. Increased incorporation of labelled phosphate 
into these lipids has been reported when cholinergic agents are added to incubated slices of brain 
(BROSSARD and QUASTEL, 1963; HOKIN and HOKIN, 1955), to homogenates (REDMAN and HOKIN, 
1964; DURELL and SODD, 1964), and to synaptic nerve-ending preparations (SCHACHT and AGKANOFF, 
1972). Stimulation of labelling of PhI and PhA has also been reported in brain slices (PUMPHREY, 1969) 
and in excised sympathetic ganglia (LARRABEE and LEICHT, 1965) that have been stimulated electrically. 
Although these findings suggest that functional activity in the intact brain could affect phospholipid 
turnover, there have been few studies in vivo. In the present paper, we report the effect of pentyl- 
enetetrazol and electrically-produced convulsions on incorporation of [32P]-orthophosphate and 
[3H]-nz.yo-inositol into brain phospholipids at various times following injection of isotope. 
METHODS 
Common goldfish (Carassius auratus) weighing approximately 10 g (brain weight, 80-100 mg) were 
obtained from Ozark Fisheries (Stoutland, Mo.). Isotopic compounds were injected intracranially as 
described previously (AGRANOFF and KLINGER, 1964). Brains were removed following spinal section 
and were rapidly rinsed with isotonic saline and frozen on dry-ice. They were homogenized in chloro- 
form-methanol-HCl (HAJRA, SEGUIN and AGRANOFF, 1968) and the extracted lipids were separated 
by thin-layer chromatography (HOLLANDER, HALLENBECK and AGRANOFF, 1970). Radioactive lipids 
were located following radioautography and were subsequently scraped from the TLC plate and 
counted by liquid scintillation spectrometry. When [3H] and ["PI incorporation were measured in 
the same experiment, lipids were oxidized in a Packard Tri-Carb Sample Oxidizer and the recovered 
3HOH was counted separately. 
RESULTS 
Time course. Studies on the basal incorporation of 3zP1 into the aqueous HC1-soluble fraction 
and into various phospholipids demonstrated that about 15 per cent of the injected 32Pi entered the 
brain in 2 5  min and that by 15-30 min, 30 per cent of the injected dose (5-8 x lo6 c.p.m.) was 
recovered in the brain (Fig. la). The initial rate of incorporation of 3zPi into lipids was greatest for 
PhA, followed in descending order by PhIP, PhIP, and PhI. Significant incorporation into phos- 
phatidyl choline (PhC) was detected only after 15 min and into phosphatidyl ethanolamine (PhE) 
after 30 min. [3H]-Myo-inositol (Fig. 2) entered the brain less efficiently than 3zPi and was present in 
the lipid fraction primarily as PN. Some labelled PhIP and PNP2 were seen at later times. Radio- 
activity in the aqueous, HC1-soluble fraction was > 98 per cent free inositol. 
Effects of Pentylenetetrazol (PTZ) or Electroconvulsive shock (ECS). Experimental animals received 
1.5 p g  of PTZ (Metrazol, Knoll Pharmaceuticals) intraperitoneally 5 min after injection of 32Pi or 
[3H] myo-inositol intracranially. Convulsions started 1-3 rnin after the PTZ injection and lasted 2-5 
min. Incorporation of precursor into each lipid was expressed as a percentage of that for the control 
group (Figs. 1B and 2B). With both 32Pi and [3H] myo-inositol, no statistically significant changes in 
the aqueous, HC1-soluble fraction radioactivity resulted from the PTZ injection. There was, however, 
a marked stimulation of incorporation of 32Pi into PhI, PhA and PhIP, ( P  < 0.01) at the first time 
This work was supported by NIH grant NB 3101. 
Abbreviations used: PhA, phosphatidic acid; PhC, phosphatidyl choline, PhE, phosphatidyl 
ethanolamine; PhI, phosphatidyl inositol; PhIP, phosphatidyl inositol phosphate; PhIPz, phos- 
phatidyl inositol diphosphate; ECS, electroconvulsive shock; PTZ, pentylenetetrazol. 
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FIG. 1 .-(a) Incorporation of 32Pi nto phospholipids and aqueous, HC1-soluble fraction 
as a function of time after the fish received 10 p1 of H, 32P04 (carrier-free, neutralized 
with NaHC03) and 10 pCi (7.5 pmol) of [3H]-myo-inositol intracranially in a volume of 
10 p1. At the times indicated, fish were sacrificed and lipids were extracted as described in 
Methods. Each point represents the mean of 3 groups of 4 pooled fish brains. 
(b) Stimulation of labelling as a function of time after PTZ treatment. Fish were 
treated as in controls (in A )  but received 1.5 mg of PTZ injected in 10 pl  intraperitoneally 
at 5 min after the intracranial injection of radioisotope. Statistical significance of the 
stimulation of labelling of PhA, PhI, PhIP and PhIPz at 15 min: P < 0.01 ; at 60 min: 
PhA, PhIP and PhIPz: N.S.; PhI: P <0.025. Symbols: -a -, aqueous HC1-soluble 
fraction; - 0 -, PhA; - 0 -, PhI; - 0 -, PhIP; - Q -, PhIPz; - 0 -i 
PhC; - 0 -, PhE. 
point measured (10 rnin after PTZ injection and 2-4 min after convulsions had ceased). The magnitude 
of this effect decreased rapidly with time, and by 60 min, it remained significant only for PhI (P < 
0.025). Contrary to the labelling observed in these acidic phospholipids, the incorporation of 32P 
TABLE 1.-INFLUENCE OF ELECTROCONVULSIVE SHOCK ON LIPID LABELLING 
d.p.m. of 32P/fish brain 
Fraction Control ECS % change 
Acid-soluble 3780 & 380 3730 f 580 N.S. 
Total lipid extract 31 & 3-40 35.7 & 7.8 N.S. 
PhA 9.7 f 0.60 12.3 f 1.50 +27* 
PhI 3.8 & 0.30 5.0 5 060 +32* 
PhIP 11.2 f 070 10.7 & 0.90 N.S. 
PhIPz 5.3 -+ 0.50 6.1 f 0.20 + l 5 t  
* P < 0.02. 
t P < 0.05, 
Fish were injected intracranially with 10 pCi of carrier-free 32Pi, and 
experimental animals received ECS 10 min later (10 mA, 60 Hz, 1 s). 
Control and shocked fish were sacrificed at 5 rnin thereafter and lipids 
were extracted as described in Methods. Values represent the means &s.D. 
of radioactivity for 16 fish, analysed in groups of 4. 
N.S. = No significant change. 
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FIG. 2.-(a) Incorporation of [3H[-myo-inositol into phospholipids and aqueous, HCI- 
soluble fraction as a function of time after incranial injection of radioisotope. See 
legend to Fig. 1 for details and key to symbols. 
(b) Stimulation of labelling as a function of time after PTZ treatment; see legend 
to Fig. 1. Statistical significance of stimulation of labelling of PhI at 15 min: P i O . 0 1 .  
PhIP and PhlPz: N.S. 
into PhC and PhE was decreased by the PTZ treatment. Stimulation by PTZ of incorporation of 
[3H] myo-inositol into PhI paralleled that seen with 32Pi, while labelling of PhIP or PhIPz appeared 
much less marked. 
Electrically-induced convulsions (DAVIS and HIRTZEL, 1970) also altered the lipid labelling 
pattern (Table 1). As with PTZ, no significant change in the total radioactivity of the aqueous, 
HC1-soluble fraction was detected, and the effects on lipid labelling, while smaller than those seen 
with FTZ, were qualitatively similar. 
D I S C U S S I O N  
lncnrnoration of 32P. in to  hrain nhosnholinidq has heen renorted to decrease in mice suhiected to 
HAUSER and LEBARON, 1964) indicate that there are no changes under these conditions. HAYASHI 
ri al. (1962) have reported increased labelling of several phospholipid fractions which include PhA 
and PhI and decreased labelling of a fraction containing PhE and PhIPz in rabbit brain following 
electrically-induced convulsions. MARCOLIS and HELLEK (1956) found increased incorporation of 
[3H]-inositol into PhI of rat brain after administering cholinergic agents, but did not report the 
effects on the labelling of PhIP or PhIP,. In the present experiments, we reasoned that short incuba- 
tion periods should be examined, since a single spurt in labelling may become undetectable in the 
presence of a significant constant basal rate of labelling. Goldfish seemed to be advantageous for such 
studies since the injection of 32P, over the brain permits a more rapid, direct entry of radioactivity than 
that via the blood. The intracranial route would appear to have an advantage over intracerebral 
injections, particularly over a short period of time, since incorporation is more uniform. The relatively 
slow metabolic rate of poikilotherms is also useful since it provides some assurance that pre-equili- 
brium kinetics can be established and that post-mortem changes, known to occur in PhIP and PhIP,, 
will be minimal. The relative degree of labelling of specific phospholipids at early times is different in 
the fish than that reported in the chick (KOZAK and WELLS, 1969) and in rat brain (FKIEDEL and 
SCHANBERG, 1971), perhaps representing a species difference. We have observed that when minces or 
homogenates of goldfish brain are incubated with 32P1, the degree of PhA labelling surpasses that 
of the inositides. In guinea pig brain homogenate and nerve-ending preparations incubated with 
1420 Short communication 
3zPi, we have observed, however, that PhIP and PhIP, are more highly labelled than PhA at early 
times (SCHACHT and AGRANOFF, 1972; HOLLANDER et a/.,  1970). In each instance, the phosphomono- 
ester is presumed to be equilibrating with a pool of [32P]ATP via a combination of kinases and hydro- 
lases, while PhI becomes labelled more slowly and reflects its synthesis, as can also be seen from 
[3H]-inositol incorporation. 
The significance of the convulsant-related changes in relation to the in vitro effects of cholinergic 
agents is not clear. Although cholinergic mechanisms have been invoked to explain the action of PTZ 
(HAHN, 1960; GIARMAN and PEPEU, 1964), we think it more likely that events related to increased 
brain activity mediate the action of PTZ and ECS on lipid labelling. For example, there is a suggestive 
decrease in radioactivity in the aqueous, HC1-soluble fraction of brain in the PTZ-treated animals by 
30 min (Fig. 1 b). This may reflect efflux of precursor from the brain as a result of increased cerebral 
blood flow (INGVAR and LASSEN, 1962) which in turn could indicate increased metabolism. The 
parallel stimulation of the incorporation of 32Pi and [3H]-inositol into PhI argues against the pos- 
sibility that changes in specific radioactivity of ATP alone could account for the observed effects. In 
four separate experiments to directly compare effects of cholinergic agents in vivo with their actions 
in vifro, 3 pg of carbamyl choline or 60-100 pg of eserine were injected intracranially into each of 4 
goldfish 5 min following the intracranial injection of 3zPi, and the fish were killed after 15 min of 
in vivo labelling. In each instance PhI labelling in the drug-treated fish was twice that of saline-injected 
animals, while PhA, PhIP and PhIPz were increased about 15fold. As with PTZ and ECS, there was 
no significant effect on the aqueous, HCI-soluble radioactivity. 
It has been proposed (HOKIN and HOKIN, 1964; DURELL, GARLAND and FRIEDEL, 1969) that the 
rapid 32P-labelling of phospholipids reflects a cyclic reaction sequence in which a cholinergic drug 
stimulates cleavage of endogenous phospholipid to yield diglyceride, which is then reincorporated via 
diglyceride kinase and the CDP-diglyceride pathway (AGRANOFF, BRADLEY and BRADY, 1958 ; PAULUS 
and KENNEDY, 1960). Both PhI and PhIP + PhIPz (GARLAND and DURELL, 1971) have been suggested 
as sources of the diglyceride, although many questions have been raised regarding these possibilities 
(SCHACHT and AGRANOFF, 1972). Whether the inositide turnover reflects synaptic events (LARRABEE 
and LEICHT, 1965), axonal permeability (KAI and HAWTHORNE, 1969) or other aspects of brain 
metabolism, it is clear that in uivo effects similar to those seen in vitro can be elicited and that the 
magnitude of the changes is large when measurements are made at times prior to equilibration. 
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